| Pharmaceutical active ingredients: |
| Eprosartan MesylateHydrochlorothiazide |
| Available forms, composition and doses of Emestar Plus: |
| N / A |
| Emestar Plus medical category: |
| Human:Angiotensin II receptor antagonists |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C09DA02 - Eprosartan and diuretics |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Trommsdorff Arzneimittel |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Teveten | Eprosartan Mesylate | Abbott; DKSH; Edward Keller; GlaxoSmithKline; Kos Pharmaceuticals; Orion Pharma; Sanofi-Aventis; Solvay; The Glory Medicina; Zuellig Pharma |
| Teveten Mono | Eprosartan Mesylate | Solvay |
| Tevetens | Eprosartan Mesylate | Solvay |
| Tevetenz | Eprosartan Mesylate | Solvay; Italmex |
| Coteveten | Eprosartan Mesylate; Hydrochlorothiazide | Solvay |
| Eprotan Plus | Eprosartan Mesylate; Hydrochlorothiazide | Mepha |
| Teveten HCT | Eprosartan Mesylate; Hydrochlorothiazide | Abbott; Biovail Pharmaceuticals; Kos Pharmaceuticals; Solvay |
| Teveten Plus | Eprosartan Mesylate; Hydrochlorothiazide | Abbott; DKSH; Kos Pharmaceuticals; Solvay; The Glory Medicina; Zuellig Pharma |
| Tevetenz Dox | Eprosartan Mesylate; Hydrochlorothiazide | Solvay; Italmex |
| Eupneron | Eprozinol Dihydrochloride | E Pharma Laboratoire; Lyocentre Laboratoires |